Free Trial
NASDAQ:XXII

22nd Century Group (XXII) Stock Price, News & Analysis

22nd Century Group logo
$3.15 -0.10 (-3.08%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$2.98 -0.18 (-5.56%)
As of 02/21/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About 22nd Century Group Stock (NASDAQ:XXII)

Key Stats

Today's Range
$3.07
$3.29
50-Day Range
$3.05
$8.10
52-Week Range
$3.01
$581.85
Volume
82,495 shs
Average Volume
162,094 shs
Market Capitalization
$5.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina.

Receive XXII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 22nd Century Group and its competitors with MarketBeat's FREE daily newsletter.

XXII Stock News Headlines

22nd Century Group (NASDAQ:XXII) Given "Sell (E+)" Rating at Weiss Ratings
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."
If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.
22nd Century files to sell 104,124 shares of common stock for holders
See More Headlines

XXII Stock Analysis - Frequently Asked Questions

22nd Century Group's stock was trading at $5.31 at the beginning of 2025. Since then, XXII shares have decreased by 40.7% and is now trading at $3.15.
View the best growth stocks for 2025 here
.

22nd Century Group, Inc. (NASDAQ:XXII) issued its quarterly earnings data on Thursday, November, 4th. The biotechnology company reported ($31,104.00) EPS for the quarter, missing analysts' consensus estimates of ($20,736.00) by $10,368.00. The biotechnology company earned $7.81 million during the quarter, compared to analysts' expectations of $8 million.

Shares of 22nd Century Group reverse split on the morning of Tuesday, December 17th 2024. The 1-135 reverse split was announced on Friday, December 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 16th 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Top institutional shareholders of 22nd Century Group include Anson Funds Management LP (2.88%) and Concourse Financial Group Securities Inc.. Insiders that own company stock include Lawrence Firestone and John Franzino.
View institutional ownership trends
.

Shares of XXII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that 22nd Century Group investors own include NVIDIA (NVDA), Meta Platforms (META), Canopy Growth (CGC), Advanced Micro Devices (AMD), Cara Therapeutics (CARA), Micron Technology (MU) and Novavax (NVAX).

Company Calendar

Last Earnings
11/04/2021
Today
2/21/2025
Next Earnings (Estimated)
3/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Industry
Cigarettes
Sub-Industry
Cannabis
Current Symbol
NASDAQ:XXII
Employees
80
Year Founded
N/A

Profitability

Net Income
$-140,770,000.00
Net Margins
-144.09%
Pretax Margin
-120.10%

Debt

Sales & Book Value

Annual Sales
$32.20 million
Book Value
($417.78) per share

Miscellaneous

Free Float
1,715,000
Market Cap
$5.42 million
Optionable
Optionable
Beta
1.57
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:XXII) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners